Participants received once-weekly subcutaneous retatrutide at 4 mg, 9 mg, or 12 mg, or placebo, for 80 weeks
The dosing schedule follows a gradual ramp-up to help minimize side effects and improve tolerance
Ingredients & Dosage Inactive ingredients / formulation base Molecular Formula: C62H98N16O22 Molecular Weight: ~1,419 Da Amino Acid Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val SKU: BPN0008MG Shipping & Storage Shipping: Orders ship within 12 business days
DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1alpha in type 2 diabetic patients with incipient nephropathy
Association between hippocampal microglia, AD and LATE-NC, and cognitive decline in older adults
10.1038/s41420-025-02617-3 75 ShresthaR.JohnsonE.ByrneF